Amount Raised
$100 Million
Round Type
Series B
CambridgeHealthcareDescription
Goldfinch Bio, a clinical stage biotechnology company focused on discovering and developing precision medicines for the treatment of kidney diseases, today announced the closing of an oversubscribed Series B financing, which raised $100 million. The financing was led by Eventide Asset Management, and included new investors Wellington Management Company, Ally Bridge Group, funds and accounts managed by BlackRock, Casdin Capital, LLC and Irving Investors, along with existing investors Gilead Sciences, Yonjin Capital, Schroeder Adveq and other undisclosed institutional investors. In connection with the financing, Joy Ghosh, Ph.D., a senior research analyst at Eventide Asset Management, will join the Company’s Board of Directors.
Quick answer
Goldfinch Bio, Inc. raised $100 Million in a Series B round, dated June 30, 2020. Goldfinch Bio, Inc. is based in Cambridge, Maryland, United States.
- How much did Goldfinch Bio, Inc. raise?
- Goldfinch Bio, Inc. raised $100 Million in a Series B round on June 30, 2020.
- What does Goldfinch Bio, Inc. do?
- Goldfinch Bio, Inc. is a clinical stage biotechnology company that leverages a genomics-based, precision medicine approach to discovering and developing kidney disease treatments.
- Where is Goldfinch Bio, Inc. based and how big is it?
- Goldfinch Bio, Inc. is based in Cambridge, Maryland, United States.
- Who are the decision-makers at Goldfinch Bio, Inc?
- Fundz holds 1 contact at Goldfinch Bio, Inc. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Healthcare around the same time
Companies in the same sectors as Goldfinch Bio, Inc. that raised within 45 days of this round, from Fundz verified event records.
- NeuroRescue, Inc. raised $200K (Pre-Seed) on August 14, 2020.
- CirrusMD raised $67K (Seed) on August 14, 2020.
- SpIntellx, Inc. raised $463K (Seed) on August 14, 2020.
- Jumo Health raised $2.3M (Seed) on August 14, 2020.
- Phosplatin Therapeutics LLC raised $18M on August 14, 2020.
- Vicarious Surgical raised $13M on August 14, 2020.
Who to call at Goldfinch Bio, Inc., and when
A new round usually means Goldfinch Bio, Inc. is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Goldfinch Bio, Inc. raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Goldfinch Bio, Inc., from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Goldfinch Bio, Inc.. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Goldfinch Bio, Inc. raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Funding Insights
What this usually meansGoldfinch Bio, Inc. raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.